Chemoinformaics analysis of (8-METHYL-8-AZABICYCLO[3.2.1]OCTAN-3-YL) 3,4-DIMETHOXYBENZOATE
| Molecular Weight | 305.374 | nRot | 4 |
| Heavy Atom Molecular Weight | 282.19 | nRig | 0 |
| Exact Molecular Weight | 305.163 | nRing | 3 |
| Solubility: LogS | -5.322 | nHRing | 2 |
| Solubility: LogP | 5.377 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 48.0342 |
| nHD | 0 | BPOL | 30.8598 |
| QED | 0.492 |
| Synth | 2.186 |
| Natural Product Likeliness | 1.113 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.316 |
| MDCK | 0.0000128 |
| BBB | 0.805 |
| PPB | 0.964878 |
| VDSS | 2.757 |
| FU | 0.0303218 |
| CYP1A2-inh | 0.956 |
| CYP1A2-sub | 0.604 |
| CYP2c19-inh | 0.553 |
| CYP2c19-sub | 0.699 |
| CYP2c9-inh | 0.51 |
| CYP2c9-sub | 0.818 |
| CYP2d6-inh | 0.082 |
| CYP2d6-sub | 0.08 |
| CYP3a4-inh | 0.093 |
| CYP3a4-sub | 0.143 |
| CL | 7.2 |
| T12 | 0.213 |
| hERG | 0.045 |
| Ames | 0.007 |
| ROA | 0.047 |
| SkinSen | 0.754 |
| Carcinogencity | 0.06 |
| EI | 0.98 |
| Respiratory | 0.506 |
| NR-Aromatase | 0.006 |
| Antiviral | Yes |
| Prediction | 0.724863 |